Brief: Heron Therapeutics Receives A Paragraph IV Certification Notice From Mylan Pharmaceuticals Inc.
Dec 22 (Reuters) - Heron Therapeutics Inc HRTX.O :
* HERON THERAPEUTICS INC - ON DECEMBER 18, CO RECEIVED A
PARAGRAPH
IV CERTIFICATION NOTICE FROM MYLAN PHARMACEUTICALS INC.
* HERON THERAPEUTICS INC - CURRENTLY REVIEWING NOTICE,
INTENDS TO
"VIGOROUSLY DEFEND AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS"
PROTECTING APONVIE
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop